Approval
The FDA approved Wegovy tablets on December 22, 2025. They are indicated for adults with obesity, or with overweight and at least one weight-related condition, and to lower the risk of heart attack, stroke and cardiovascular death in adults with established cardiovascular disease and either obesity or overweight. Both uses go with a reduced-calorie diet and more physical activity.
The tablets reached US pharmacies in early January 2026. A second weight-loss pill, Foundayo, was approved in April 2026. What online programs charge for the Wegovy pill at each dose is on our Wegovy pill cost page, and every GLP-1 pill is compared on GLP-1 pills.
How it differs from other semaglutide
The Wegovy pill contains semaglutide, the same molecule as the weekly Wegovy injection and the diabetes tablet Rybelsus. Its top dose of 25 mg is much higher than the diabetes tablets, because only a small share of swallowed semaglutide is absorbed.
Like Rybelsus, the tablet uses an absorption enhancer, and the label has rules about taking it on an empty stomach with a little water before eating.
Clinical evidence
The weight approval rests on the OASIS 4 trial. People on oral semaglutide 25 mg lost 13.6% of their body weight on average after 64 weeks (FDA label, all randomized patients), compared with 2.4% on placebo. About 59.8% of people on the pill lost at least 10% of their weight.
The heart indication draws on the SELECT trial of injected semaglutide.
Forms, doses and side effects
Wegovy tablets come in 1.5 mg, 4 mg, 9 mg and 25 mg strengths. The label raises the dose step by step, a process called titration.
The most common side effects are nausea, vomiting, diarrhea and constipation. The label carries the same boxed warning about thyroid C-cell tumors as other semaglutide products. Our pill vs. shot page compares daily tablets with weekly injections.
Wegovy pill prices at online programs
See also
References
- Wegovy (semaglutide) injection and tablets, prescribing information, DailyMed 2026. dailymed.nlm.nih.gov
- Wegovy prescribing information 2026 (OASIS 4). accessdata.fda.gov
- Wegovy pill FDA approval, Novo Nordisk company announcement, December 22, 2025
Last updated . Category: Medications. Browse all 38 WikiTelehealth entries.